Physician profile
Robert V Michael
NPI 1629224183
$2,344.91
in general payments reported to CMS, 2019-2025
12 companies · $88.04 in 2025
The $88.04 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,889 · 2020: $14.68 · 2021: $46.71 · 2022: $35.27 · 2023: $38.19 · 2024: $233 · 2025: $88.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,872.00 | 2019 | |
| Medtronic, INC. | $170.29 | 2022-2024 | Linq II |
| Exact Sciences Corporation | $132.18 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $33.66 | 2020-2021 | |
| Alkermes, INC. | $22.85 | 2024 | Vivitrol |
| Inogen, INC. | $19.86 | 2022 | |
| Dexcom, INC. | $18.19 | 2023 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $17.00 | 2025 | Airsupra |
| Glaxosmithkline, LLC. | $16.84 | 2019 | |
| Pfizer INC. | $15.00 | 2021 | |
| Amgen INC. | $14.31 | 2025 | Evenity |
| Bioventus LLC | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.